Zoomd to Present at August 2020 Lytham Partners Virtual Investor Growth Conference

Zoomd to Present at August 2020 Lytham Partners Virtual Investor Growth Conference VANCOUVER, Canada, Aug. 12, 2020 /PRNewswire/ — Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) https://www.zoomd.com and its wholly-owned subsidiary Zoomd Ltd. (collectively, “Zoomd” or the “Company”), the marketing tech (MarTech) user-acquisition and engagement platform, is pleased to announce that it is scheduled to participate in a virtual presentation…

Aurora Spine Corporation to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference

Aurora Spine Corporation to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference ARLSBAD, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) is scheduled to participate in a virtual presentation and fireside chat at the August 2020 Lytham Partners Virtual Investor Growth Conference on…

S&W to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference

S&W to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference LONGMONT, Colo., Aug. 12, 2020 /PRNewswire/ — S&W Seed Company (Nasdaq: SANW) is scheduled to participate in a virtual presentation and fireside chat at the August 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, August 19, 2020 at 12:00pm ET (9:00am PT). A webcast of the presentation will be posted…

INVO Bioscience to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference

INVO Bioscience to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference SARASOTA, Fla., Aug. 6, 2020 /PRNewswire/ — INVO Bioscience, Inc. (OTCQB: INVO), (“the Company”, “INVO”) a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, is scheduled to participate in…

Zoomd LTD

TSX.V: ZOMD Sector: Technology Industry: Communication Services Zoomd, founded in 2012 and began trading on the TSX Venture Exchange in September 2019, offers a site search engine to publishers, and a mobile app user-acquisition platform, integrated with a majority of global digital media, to advertisers. The platform unifies more than 600 media sources into one…

Else Nutrition Holdings Inc.

TSXV: BABY / OTCQB: BABYF / FSE: 0YL Sector: Consumer Industry: Healthy Living Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly…

SANUWAVE Health, Inc.

OTCQB: SNWV Sector: Healthcare Industry: Medical Devices SANUWAVE Health, Inc. is a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses,…

ChromaDex Corporation

Nasdaq: CDXC Sector: Healthcare Industry: Biotechnology ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of NAD and its impact on human health. Its flagship ingredient, NIAGEN® nicotinamide…

LexaGene Holdings, Inc.

TSXV: LXG / OTCQB: LXXGF Sector: Healthcare Industry: Medical Devices LexaGene Holdings, Inc., (“LexaGene”), is a commercial molecular diagnostics company selling a patented, fully automated, pathogen detection system for point-of-need diagnostics, called MiQLab™. The on-site rapid testing solution has use in in veterinary diagnostics, food safety, open-access markets such as clinical research, agricultural testing, and biodefense. End-users simply…

MannKind Corporation

Nasdaq: MNKD Sector: Healthcare Industry: Biotechnology MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company’s first FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the United States, where…